GE Healthcare Technologies Inc (GEHC.N): A Good Quarter as MedTech Sentiment Starts to Shift

研报英文原文证据摘录

GE Healthcare Technologies Inc (GEHC.N): A Good Quarter as MedTech Sentiment Starts to Shift

al products. Any decision to purchase securities or financial products

mentioned in the Product must take into account existing public information on such security or the financial products or any

registered prospectus.

The Product is made available in Thailand through Citicorp Securities (Thailand) Ltd., which is regulated by the Securities and

Exchange Commission of Thailand. 399 Interchange 21 Building, 18th Floor, Sukhumvit Road, Klongtoey Nua, Wattana

,Bangkok 10110, Thailand.

Disclosure for investors in the Republic of Turkey: The Product is made available in Turkey through Citibank AS which is

regulated by Capital Markets Board. Tekfen Tower, Eski Buyukdere Caddesi # 209 Kat 2B, 23294 Levent, Istanbul, Turkey.

Under Capital Markets Law of Turkey (Law No: 6362), the investment information, comments and recommendations stated

here, are not within the scope of investment advisory activity. Comments and recommendations stated here rely on the

individual opinions of the ones providing these comments and recommendations. These opinions may not fit to your financial

status, risk and return preferences. For this reason, to make an investment decision by relying solely to this information stated

here may not bring about outcomes that fit your expectations. Furthermore, Citi Research is a division of Citigroup Global

Markets Inc. (the “Firm”), which does and seeks to do business with companies and/or trades on securities covered in this

research reports. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the

objectivity of this report, however investors should also note that the Firm has in place organisational and administrative